Skip to content

Evaluation of the implementation effect of digital therapy for chronic obstructive pulmonary disease at the grassroots level

Evaluation of the implementation effect of digital therapy for chronic obstructive pulmonary disease at the grassroots level

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500114470
Enrollment
Unknown
Registered
2025-12-12
Start date
2025-12-25
Completion date
Unknown
Last updated
2025-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

Control group:The routine management of the community health service center
Intervention group:Intervene by applying digital therapy on the basis of conventional management

Sponsors

Tianjin Fourth Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria outlined in the Guidelines for the Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease (2021 Revised Edition); 2. Voluntarily participate in this study and sign an informed consent form; 3. Be a permanent resident of Tianjin Municipality; 4. Possess the ability to use a smartphone and, following instruction, operate the digital therapy application; 5. Not currently engaged in any other internet-based smart health management programmes.

Exclusion criteria

Exclusion criteria: 1. Individuals with visual, auditory, or cognitive impairments preventing normal communication; 2. Those with a history of psychiatric disorders rendering them non-cooperative; 3. Patients with concomitant severe organic heart disease, malignant tumours, hepatic or renal dysfunction, or similar conditions; 4. Individuals unable to utilise smart medication sensors, or those in a state of extreme physical debility.

Design outcomes

Primary

MeasureTime frame
COPD Assessment Test score;Modified British medical research council score;Pulmonary function test results;The incidence rate of acute exacerbation of chronic obstructive pulmonary disease during the intervention period;

Secondary

MeasureTime frame
Eight-item Morisky Medication Adherence Scale score;St. George's Respiratory Questionnaire score;Five-level Five-dimensional Health Scale score;

Countries

China

Contacts

Public ContactDu Yue

Tianjin Fourth Central Hospital

duyue@tmu.edu.cn+86 189 2001 5698

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026